Lipoxygenase and Phospholipase

Mechanisms of lipid peroxidation that have been implicated in atherosclerosis may be pertinent to RA. Cellular lipoxygenase enzymes may promote LDL modification by inserting hydroperoxide groups into unsaturated fetty-acid side chains of the LDL complex (Yla-Herttuala etal., 1990). 15-Lipoxygenase has been implicated as an initiator of LDL oxidation (Cathcart etal., 1991) whilst 5-lipoxygenase does not appear to be involved (Jessup et al., 1991). Products of activated lipoxygenase enzymes within inflammatory synovial fluid surest that this pathway could be activated in RA (Costello etal., 1992). 

---

Timegadine, a guanidine derivative, inhibits cyclo-oxygenase, lipoxygenase, and phospholipase activity. Reported adverse effects are skin rashes, oral lesions, epigastric pain, nausea, dysuria, dizziness, vertigo, and sleep disturbances. Liver enzyme changes and pneumonitis have also been described (1-4). 

Recently, Pseudopterosin C, a diterpene riboside isolated from the gorgonian corals Pseudopterogorgia bipinata and P. elisabethae [134] was launched by Estde Lauder as an additive to anti-aging cosmetics. It exhibits potent antiinflammatory and analgesic activities by reversibly affecting both, lipoxygenase and phospholipase A2 [135]. 

---